| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11926-018-0773-X |
| P698 | PubMed publication ID | 30123926 |
| P50 | author | Ricard Cervera i Segura | Q53547424 |
| P2093 | author name string | Claudia Mendoza-Pinto | |
| Mario García-Carrasco | |||
| P2860 | cites work | Murine monoclonal antibody 26 raised against tetanus toxoid cross-reacts with beta2-glycoprotein I: its characteristics and role in molecular mimicry. | Q44193951 |
| Antiphospholipid antibodies in patients with purported 'chronic Lyme disease'. | Q44281373 | ||
| 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. | Q51289629 | ||
| Antiphospholipid syndrome following toxoplasma retinochoroiditis. | Q51422671 | ||
| Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin. | Q52652019 | ||
| The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. | Q53189388 | ||
| High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. | Q64884874 | ||
| Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population | Q68343284 | ||
| Prevalence and disease associations of certain autoantibodies in elderly patients | Q74345970 | ||
| Catastrophic antiphospholipid syndrome and sepsis. A common link? | Q80261265 | ||
| Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus | Q81512797 | ||
| Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice | Q82205263 | ||
| Lack of antiphospolipid antibodies in long-term cardiac rheumatic fever | Q84866031 | ||
| Rheumatic fever associated with antiphospholipid syndrome: systematic review | Q26859847 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus | Q28365920 | ||
| Systematic review of case reports of antiphospholipid syndrome following infection. | Q30243901 | ||
| Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production? | Q30363962 | ||
| Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. | Q33331368 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome | Q33346556 | ||
| Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. | Q33357573 | ||
| Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine | Q33433165 | ||
| Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence. | Q33439468 | ||
| Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study | Q33443797 | ||
| 'Primary', 'secondary' and other variants of the antiphospholipid syndrome | Q33490042 | ||
| Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura | Q33491459 | ||
| Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group | Q33500894 | ||
| Central serous chorioretinopathy and Helicobacter pylori | Q34526768 | ||
| Characterization of antiphospholipid antibodies in chronic hepatitis B infection | Q34729294 | ||
| Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome | Q35555909 | ||
| Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus | Q35711767 | ||
| Infectious origin of the antiphospholipid syndrome | Q36339540 | ||
| Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers. | Q36923241 | ||
| Antiphospholipid antibodies, antiphospholipid syndrome and infections | Q37092997 | ||
| Viral hepatitis and anti-phospholipid antibodies positivity: A systematic review and meta-analysis | Q38402084 | ||
| Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry | Q38957667 | ||
| Antibodies to anionic phospholipids and cofactors in kala-azar. Comparative study with malaria, toxoplasmosis and "autoimmune diseases". | Q39469933 | ||
| Catastrophic Antiphospholipid Syndrome Triggered by Fulminant Chikungunya Infection in a Patient With Systemic Lupus Erythematosus | Q40123473 | ||
| Hyperferritinemic syndrome: Still's disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients | Q40144972 | ||
| Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. | Q40478898 | ||
| Anticardiolipin antibodies are not associated with rheumatic heart disease | Q40590429 | ||
| Prevalence, significance, and specificity of antibodies to phospholipids in Q fever | Q40705182 | ||
| Anticardiolipin antibodies in acute rheumatic fever | Q40731164 | ||
| Human immunodeficiency virus type 1-related transient neurological deficits | Q40929005 | ||
| A circulating anticoagulant in lepromatous leprosy | Q41065601 | ||
| M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies | Q41767987 | ||
| Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. | Q41930841 | ||
| Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar | Q43699731 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| infectious disease | Q18123741 | ||
| P304 | page(s) | 62 | |
| P577 | publication date | 2018-08-20 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant) | |
| P478 | volume | 20 |
| Q64092947 | Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome |
| Q108395894 | Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor |
| Q99583920 | Autoimmunity as the comet tail of COVID-19 pandemic |
| Q92758910 | Catastrophic Antiphospholid Syndrome - An Unusual Case Report |
| Q97588508 | Coagulopathy in COVID-19: Focus on vascular thrombotic events |
| Q99608837 | Deep Vein Thrombosis and Pulmonary Embolism in the Setting of Mycoplasma Infection |
Search more.